These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 33342806)

  • 1. Sildenafil enhances cisplatin-induced apoptosis in human breast adenocarcinoma cells.
    Hassanvand F; Mohammadi T; Ayoubzadeh N; Tavakoli A; Hassanzadeh N; Sanikhani NS; Azimi AI; Mirzaei HR; Khodamoradi M; Goudarzi KA; Pourghadamyari H; Zaimy MA
    J Cancer Res Ther; 2020; 16(6):1412-1418. PubMed ID: 33342806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.
    El-Naa MM; Othman M; Younes S
    Drug Des Devel Ther; 2016; 10():3661-3672. PubMed ID: 27895461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Synergistic Effect of Sildenafil and Green Tea Polyphenols on Breast Cancer Stem Cell-like Cells and their Parental Cells: A Potential Novel Therapeutic Approach.
    Sharif MS; Mohseni HS; Khanavi M; Ghadami S; Jafarzadeh E; Tavajohi S; Aliebrahimi S; Ostad SN
    Anticancer Agents Med Chem; 2024 Feb; 24(4):304-315. PubMed ID: 37957912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the phosphodiesterase-5 inhibitor, sildenafil, on sensitivity to chemotherapy in breast tumor cells.
    Di X; Gennings C; Bear HD; Graham LJ; Sheth CM; White KL; Gewirtz DA
    Breast Cancer Res Treat; 2010 Nov; 124(2):349-60. PubMed ID: 20155316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
    Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
    Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase inhibitor, pentoxifylline enhances anticancer activity of histone deacetylase inhibitor, MS-275 in human breast cancer in vitro and in vivo.
    Nidhyanandan S; Boreddy TS; Chandrasekhar KB; Reddy ND; Kulkarni NM; Narayanan S
    Eur J Pharmacol; 2015 Oct; 764():508-519. PubMed ID: 26209365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase 5 inhibitor sildenafil potentiates the antitumor activity of cisplatin by ROS-mediated apoptosis: a role of deregulated glucose metabolism.
    Rawat SG; Tiwari RK; Jaiswara PK; Gupta VK; Sonker P; Vishvakarma NK; Kumar S; Pathak C; Gautam V; Kumar A
    Apoptosis; 2022 Aug; 27(7-8):606-618. PubMed ID: 35725975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of phosphodiesterase 5 by sildenafil reduces tumor growth and potentiates tumor-killing ability of cisplatin in vivo against T cell lymphoma: Implication of modulated apoptosis, reactive oxygen species homeostasis, glucose metabolism, and pH regulation.
    Rawat SG; Tiwari RK; Kumar A
    Environ Toxicol; 2024 Apr; 39(4):1909-1922. PubMed ID: 38059649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
    Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
    World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential synergistic effect of phosphodiesterase inhibitors with chemotherapy in lung cancer.
    Domvri K; Zarogoulidis K; Zogas N; Zarogoulidis P; Petanidis S; Porpodis K; Kioseoglou E; Hohenforst-Schmidt W
    J Cancer; 2017; 8(18):3648-3656. PubMed ID: 29151951
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
    Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
    Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy of doxorubicin and Sildenafil inhibits the growth of pediatric rhabdomyosarcoma.
    Urla C; Stagno MJ; Fuchs J; Warmann SW; Schmid E
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2513-2522. PubMed ID: 35764701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rationale for Repurposing Sildenafil for Lung Cancer Treatment.
    Keats T; Rosengren RJ; Ashton JC
    Anticancer Agents Med Chem; 2018; 18(3):367-374. PubMed ID: 29110626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic insight into salinomycin mechanisms in breast cancer cell lines: synergistic effects with dasatinib and induction of estrogen receptor β.
    Bellat V; Verchère A; Ashe SA; Law B
    BMC Cancer; 2020 Jul; 20(1):661. PubMed ID: 32678032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased breast cancer cell sensitivity to cisplatin using a novel small molecule inhibitor.
    Hatzidaki E; Daikopoulou V; Apostolou P; Ntanovasilis DA; Papasotiriou I
    J Cancer Res Ther; 2020; 16(6):1393-1401. PubMed ID: 33342803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling.
    Sinha S; Sharma S; Vora J; Shah H; Srivastava A; Shrivastava N
    J Ethnopharmacol; 2018 May; 217():23-35. PubMed ID: 29427634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells.
    Czarnomysy R; Surażyński A; Popławska B; Rysiak E; Pawłowska N; Czajkowska A; Bielawski K; Bielawska A
    Mol Cell Biochem; 2017 Mar; 427(1-2):13-22. PubMed ID: 27995416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F; Duivenvoorden WC; Singh G
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing of sildenafil as antitumour; induction of cyclic guanosine monophosphate/protein kinase G pathway, caspase-dependent apoptosis and pivotal reduction of Nuclear factor kappa light chain enhancer of activated B cells in lung cancer.
    AboYoussef AM; Khalaf MM; Malak MN; Hamzawy MA
    J Pharm Pharmacol; 2021 Jul; 73(8):1080-1091. PubMed ID: 33856030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell lines.
    Ibrahim T; Liverani C; Mercatali L; Sacanna E; Zanoni M; Fabbri F; Zoli W; Amadori D
    Int J Oncol; 2013 Apr; 42(4):1263-70. PubMed ID: 23403907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.